Skip to main content

Table 3 Comparison of parameters among patients with different responses

From: Tumor angiogenesis at baseline identified by 18F-Alfatide II PET/CT may predict survival among patients with locally advanced non-small cell lung cancer treated with concurrent chemoradiotherapy

Parameters

All patients

Responders

Non-responders

P value

SUVP*

5.51 ± 2.50

4.61 ± 1.94

6.55 ± 2.74

0.039

SUVLN

3.47 ± 1.71

3.59 ± 1.81

3.33 ± 1.65

0.699

T/LN

2.04 ± 2.30

1.42 ± 0.53

2.75 ± 3.25

0.172

TBRP*

7.73 ± 6.09

5.34 ± 3.03

10.49 ± 7.58

0.023

TBRLN

4.43 ± 2.31

4.20 ± 2.53

4.68 ± 2.11

0.589

â–³D*

1.41 ± 2.0

2.78 ± 1.37

-0.16 ± 1.33

 < 0.001

  1. â–³D changes of tumor diameter before and after treatment
  2. *P < 0.05
Back to article page

Journal of Translational Medicine

ISSN: 1479-5876

Contact us